Oct 21, 2022 | Scientific Advisory Board, Trustees
The finalists for the C2 Catalyst for Precision Medicine Award significantly advance precision medicine in oncology to bring new, more personalized tests or treatments to cancer patients. As such, these finalists enhance the ability to provide the right treatment for...